These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11802090)

  • 1. Pharmacokinetic and other drug interactions in patients with AIDS.
    Dasgupta A; Okhuysen PC
    Ther Drug Monit; 2001 Dec; 23(6):591-605. PubMed ID: 11802090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common HIV drug-drug interactions.
    O'Brien LW
    AIDS Read; 1999; 9(2):104-9. PubMed ID: 12728892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interactions and protease inhibitor therapy in the treatment of HIV/AIDS.
    Klaus BD; Grodesky MJ
    Nurse Pract; 1998 Feb; 23(2):102-4, 106. PubMed ID: 9513221
    [No Abstract]   [Full Text] [Related]  

  • 4. Human immunodeficiency virus/acquired immune deficiency syndrome-related drug therapy: anesthetic implications.
    Griffis CA
    CRNA; 1999 Aug; 10(3):107-16. PubMed ID: 10723287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TB drugs interact adversely with protease inhibitors.
    AIDS Alert; 1996 Oct; 11(10):117-8. PubMed ID: 11363854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients.
    Jiménez-Nácher I; Alvarez E; Morello J; Rodriguez-Nóvoa S; de Andrés S; Soriano V
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):457-77. PubMed ID: 21342079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.
    Justesen US
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):20-31. PubMed ID: 16433887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appendix D. Summary of Evidence-based Guideline for CLINICIANS: ANTIEPILEPTIC DRUG SELECTION FOR PEOPLE WITH HIV/AIDS.
    Continuum (Minneap Minn); 2016 Feb; 22(1 Epilepsy):287-8. PubMed ID: 26844747
    [No Abstract]   [Full Text] [Related]  

  • 11. Practical perspectives on the use of tipranavir in combination with other medications: lessons learned from pharmacokinetic studies.
    Boffito M; Maitland D; Pozniak A
    J Clin Pharmacol; 2006 Feb; 46(2):130-9. PubMed ID: 16432264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interactions and antiretroviral drug monitoring.
    Foy M; Sperati CJ; Lucas GM; Estrella MM
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):212-22. PubMed ID: 24950731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining New Non-Nucleoside Reverse Transcriptase Inhibitors (RTIs) with AZT Results in Strong Synergism against Multi-RTI-Resistant HIV-1 Strains.
    Yu F; Li W; Wang L; Dai Y; Lu X; Wang Q; Xie L; Jiang S
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30004408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 protease inhibitors.
    McDonald CK; Kuritzkes DR
    Arch Intern Med; 1997 May; 157(9):951-9. PubMed ID: 9140265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV drug interactions: the good, the bad, and the other.
    Rainey PM
    Ther Drug Monit; 2002 Feb; 24(1):26-31. PubMed ID: 11805718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS).
    De Clercq E
    Adv Pharmacol; 2013; 67():317-58. PubMed ID: 23886005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The XIth International Conference on AIDS...new milestones for AIDS research and treatment.
    PI Perspect; 1996 Sep; (No 19):1-2. PubMed ID: 11363896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An appraisal of antiretroviral drugs in hemodialysis.
    Izzedine H; Launay-Vacher V; Baumelou A; Deray G
    Kidney Int; 2001 Sep; 60(3):821-30. PubMed ID: 11532078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring in children with HIV/AIDS.
    Fraaij PL; Rakhmanina N; Burger DM; de Groot R
    Ther Drug Monit; 2004 Apr; 26(2):122-6. PubMed ID: 15228151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of clinical pharmacology in the monitoring of therapy of HIV-infected subjects].
    Villani P; Cocchi L; Giacchino R; Seminari E; Regazzi MB; Maserati R
    Clin Ter; 1996 Jun; 147(6):279-93. PubMed ID: 8925637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.